Sugi Predict

Sugi Predict / Compounds / SCHEMBL1792166

SCHEMBL1792166

SCHEMBL1792166

CC(C)(C)OC(=O)Oc1ccc(C(C)(C)C)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.68
▸ MAPT P10636 4/20 0.54
▸ TDP1 Q9NUW8 2/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ RAB9A P51151 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ KDM1A O60341 1/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ CA2 P00918 2/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ THRB P10828 1/20 0.46
▸ PRSS1 P07477 1/20 0.45
▸ ACR P10323 1/20 0.45
▸ LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13866881 0.95 ELANE (0.62) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL4061370 0.90 ELANE (0.81) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL1457134 0.89 ELANE (0.68) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL198087 0.89 ELANE (0.68) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL12240212 0.89 ELANE (0.68) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL47809 0.88 MAPT (0.61) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL1792266 0.85 MAPT (0.51) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL4059798 0.84 ELANE (0.72) ELANERAB9AKDM1AMEN1KMT2A
SCHEMBL13712844 0.84 MAPT (0.58) ELANEMAPTTDP1L3MBTL1RAB9A
SCHEMBL5561643 0.84 ELANE (0.62) ELANEMAPTTDP1L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11256174-B2 Pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-02-22 — — US disclosed
US-20210106690-A1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2021-04-15 — — US disclosed
US-20200209749-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-07-02 — — US disclosed
US-10603386-B2 Protein-polymer-drug conjugates MERSANA THERAPEUTICS, INC. (US) 2020-03-31 — — US disclosed
EP-2249426-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY MITSUBISHI CHEM CORP (JP) 2019-07-10 — — EP disclosed
US-9943609-B2 Protein-polymer-drug conjugates MERSANA THERAPEUTICS, INC. (US) 2018-04-17 — — US disclosed
US-9872918-B2 Hydroxyl-polymer-drug-protein conjugates MERSANA THERAPEUTICS, INC. (US) 2018-01-23 — — US disclosed
US-20170348424-A1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2017-12-07 — — US disclosed
US-20170348424-A1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2017-12-07 — — US disclosed
US-9770519-B2 Protein-polymer-drug conjugates MERSANA THERAPEUTICS, INC. (US) 2017-09-26 — — US disclosed
US-20130101546-A1 Protein-Polymer-Drug Conjugates MERSANA THERAPEUTICS, INC. (US) 2013-04-25 — — US disclosed
US-20120321583-A1 Protein-Polymer-Drug Conjugates MERSANA THERAPEUTICS, INC. (US) 2012-12-20 — — US disclosed
US-20120308883-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-12-06 — — US disclosed
US-20120219854-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-30 — — US disclosed
US-20110123871-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY MITSUBISHI CHEMCIAL (JP) 2011-05-26 — — US disclosed
EP-2249426-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY Mitsubishi Chemical Corporation (JP) 2010-11-10 — — EP disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 — — US disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 — — US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 — — EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170348424-A1 PROTEIN-POLYMER-DRUG CONJUGATES PBRM1, CLTB, BRAP ELANE 2161/4885MAPT 1455/4885TDP1 3822/4885
US-20120321583-A1 Protein-Polymer-Drug Conjugates PBRM1, CLTB, BRAP ELANE 2161/4885MAPT 1455/4885TDP1 3822/4885
US-20200209749-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN HACL2, NEK10, ACAD10 ELANE 2892/4885MAPT 4798/4885TDP1 3226/4885
US-20210106690-A1 PROTEIN-POLYMER-DRUG CONJUGATES PBRM1, CLTB, BRAP ELANE 2616/4885MAPT 843/4885TDP1 3847/4885
US-10603386-B2 Protein-polymer-drug conjugates PBRM1, CLTB, BRAP ELANE 2679/4885MAPT 945/4885TDP1 3925/4885
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM ELANE 422/4885MAPT 3954/4885TDP1 2771/4885
US-20130101546-A1 Protein-Polymer-Drug Conjugates PBRM1, CLTB, BRAP ELANE 2479/4885MAPT 1182/4885TDP1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.